Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Removing Plasmids Eliminates Antibiotic Resistance

By Biotechdaily staff writers
Posted on 22 Nov 2004
Researchers have treated antibiotic-resistant bacteria with the drug apramycin to inhibit and ultimately remove the plasmids responsible for acquisition of the antibiotic resistance.

Plasmids are bits of extra-chromosomal DNA that are exchanged when bacteria interact. More...
Among the genes carried on plasmids are those responsible for antibiotic resistance. Investigators at the University of Illinois (Urbana-Champaign, USA) selected apramycin, an aminoglycoside antibiotic with bactericidal activity against most Gram-negative bacteria, after testing numerous other potentially useful molecules. They reported in the November 5, 2004, online edition of the Journal of the American Chemical Society that the positively charged apramycin bound to negatively charged plasmid-encoded RNA. This binding inhibited the activity of proteins that trigger plasmid reproduction.

Apramycin was used to treat bacterial cultures that were grown for 250 generations. By the end of this period, plasmids had been eliminated, and the culture had lost its antibiotic resistance.

"This is the first demonstration of a mechanistic-based approach to systematically eliminate the plasmids,” said senior author Dr. Paul J. Hergenrother, professor of chemistry at the University of Illinois. "Standard antibiotics target the cell wall, but as resistance to antibiotics emerges, there needs to be other targets. We validated that plasmids are a new target for antibiotics.”




Related Links:
University of Illinois

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.